Robert P. Giugliano, MD, FACC

Robert Giugliano

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Sanofi-Aventis(MODEST), Thrombosis Research Institute(MODEST), Samsung(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Daiichi Sankyo(SIGNIFICANT), Amgen(SIGNIFICANT), Amgen(SIGNIFICANT), Anthos Therapeutics(SIGNIFICANT), Anthos Therapeutics(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Medical Education Resources(SIGNIFICANT), Shanghai Medical Technology(MODEST), Daiichi Sankyo(SIGNIFICANT), SAJA Pharmaceutics(SIGNIFICANT), Samsung(SIGNIFICANT), Menarini(SIGNIFICANT), Servier(MODEST), Beckman Coulter(MODEST)

View Full Disclosure